This indicated the possibility of reverse causation as an explanation of our findings when considering the overall study population, due to the effect of the pathological process underpinning the progression of dementia that in the proximity of the clinical onset of the disease may affect selenoprotein P levels. This evidence concerns the gene SELENOP and dementia.